Sotac Pharmaceuticals Ltd Half Yearly Results

Gross Sales

44.39

52.59

52.19

51.64

37.73

Excise Duty

0

0

0

0

0

Net Sales

44.39

52.59

52.19

51.64

37.73

Other Operating Income

0

0

0

0

0

Other Income

3.2

0.7

0.43

0.06

0.15

Total Income

47.59

53.3

52.61

51.7

37.88

Total Expenditure

35.07

48.28

48.33

47.22

33.89

PBIDT

12.51

5.02

4.28

4.48

4

Interest

1.57

1.01

0.8

0.91

0.91

PBDT

10.95

4.01

3.49

3.58

3.08

Depreciation

2.35

1.48

1.72

1.39

1.17

Minority Interest Before NP

0

0

0

0

0

Tax

0.94

0.78

1.12

0.97

0.55

Deferred Tax

0.15

-0.03

-1.73

0.02

0.09

Reported Profit After Tax

7.51

1.77

2.38

1.2

1.27

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

6.11

1.91

2.55

1.73

1.32

Extra-ordinary Items

0

0

-0.09

0

0

Adjusted Profit After Extra-ordinary item

6.11

1.91

2.64

1.73

1.32

EPS (Unit Curr.)

5.53

1.73

2.31

1.59

1.58

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

11.05

11.05

11.05

11.05

8.05

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

28.18

9.54

8.2

8.67

10.6

PBDTM(%)

-

-

-

-

-

PATM(%)

16.91

3.36

4.56

2.32

3.36